Realm Therapeutics, a biopharmaceutical company, has named Sandy Zweifach as its new non-executive director, it was reported yesterday.

Zweifach joins the company with more than 25 years' experience in the life science industry, with a background in corporate partnering, business development, operations, private and public investing and capital raising. He is founder, president and chief executive officer of Nuvelution Pharma. Prior to this, Zweifach served in several leadership roles, including CEO of Ascendancy Healthcare, CEO and president of Pathway Diagnostics and president and CFO of Epoch Biosciences.

Alex Martin, chief executive officer, Realm Therapeutics, said, 'I am excited to welcome Sandy to the board. His background and experience in both the biopharmaceutical industry and investment banking will be helpful as we progress our pipeline and expand our optionality in 2018 and beyond.'